AIDS Action Europe is happy to launch the call for trainee applications for its regional training for the Baltic States on affordability and pricing of medications taking place.
«We learned that in Latvia government support for harm reduction programs was not systemic either. City officials may simply ban syringe exchange, as it has happened in Ventspils; or, as in Jurmala, they may refuse to recognize the problem of drug use to avoid scaring tourists away from the major resort.»
AmCham, together with the United States Embassy in Latvia and Civic Alliance of Latvia, organized the Human Development Award program for the third consecutive year to honor inspirational people, businesses and organizations. The purpose of the award is to promote human development, prosperity, and the well-being of Latvia's people.
Pan-European Networks of communities of people living with and affected by HIV, doctors and scientists call upon the Government of the Czech Republic to immediately stop the Prague Public Health Authority's persecution and intimidation of people living with HIV, and to return to evidence-based and proven practices in HIV prevention, testing and care in the Czech Republic.
The NGO ‘AGIHAS’ – a support group for people living with HIV and AIDS, and the Baltic HIV Association, as well as the Association of LGBT people and their friends ‘Mozaika’, with ViiV Healthcare’s financial support are jointly organising a major project ‘Coalition for Change’, which will take place over (the next) two years.
AGIHAS Infosheet #30 from the series „For a Better Quality of Life of PLWHA!” IS CURE NEAR? (The VIII International AIDS Society conference and the IV "Towards an HIV Cure" symposium, July 2015, Vancouver). Read here
Chair of the Steering Committee of AIDS Action Europe Anke van Dam sent a letter to the Latvian Cabinet of Ministers to express the concerns of AIDS Action Europe regarding the ongoing policies and the lack of political will in the response to HIV and AIDS in Latvia. With this letter, AIDS Action Europe joins and expresses support of the call of Latvian Civil Society Groups to follow international guidelines on treatment and prevention.
AIDS Action Europe: "We do already have a pretty good idea of the issues we will focus on during the next SC meeting which will take place in Riga in April 2015. One of the highlights of the meeting will be the possibility to meet some of the Latvian authorities and institutions and discuss HIV related issues with them. We are looking forward to this important event which will take place during the Latvian Presidency Semester."
I am writing to you to bring to your attention the alarming rates of tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB) in the European Region and to request that you take action on this issue at the upcoming 1st Eastern Partnership Ministerial Meeting on Tuberculosis organised by the Latvian government on 31st March in Riga, Latvia.
1st Eastern Partnership Ministerial Conference on Tuberculosis and Its Multi- Drug Resistance (MDR), Riga, Latvia, March 30 - 31, 2015 (National Library of Latvia, Ziedoòa hall)
HIV has become more virulent over time, not less, European study finds. Local conditions may drive viral evolution in opposite directions. Gus Cairns: "In other words, both studies could be right: HIV could currently be weakening in one part of the world, while becoming stronger in another."
It is widely believed that epidemics in new hosts diminish in virulence over time, with natural selection favoring pathogens that cause minimal disease.
October 12 marks the 10th anniversary of the direct action taken by the Russian activist group, "FrontAIDS". At that time, less than 1200 HIV-positive people in Russia were receiving ARV-s. Within a year of their series of actions (and also actions by other civil society leaders) the Russian government finally started to purchase ARV drugs. Its an important part of our region’s history.
Hepatitis С is contagious disease with known and extensive medical risks, but given Gilead’s choice to price these treatments so irresponsibly high, it makes it impossible to treat everyone who could benefit.
There is an urgent need to change our strategy for testing for HIV and hepatitis in Europe. The number of people infected is increasing and many are still not aware that they are infected. The problem is greatest in Southern and Eastern Europe, but it is also an increasing problem in other European countries, and new testing strategies are therefore required. Late diagnosis means a higher mortality rate, greater risk of onward transmission and increased financial costs.
From 21 to 28 November, the 2-nd European HIV Testing week is planned to take place. AHF Europe invites creative proposals that promote Community Based rapid HIV testing during European Testing Week.
Everyone loves a happy ending. After 33 years of a terrible epidemic, looking forward into the distance and glimpsing the end of the disease, an AIDS-free future is like seeing water on the horizon after a long, hard walk through the sands of a desert. We want it so desperately, so acutely, we can taste it.
Pharmaceutical Benefits Advisory Committee rejected the submission for Highly Specialised Drugs Program listing for sofosbuvir for the treatment of chronic hepatitis C on the basis of unacceptably high and likely underestimated cost-effectiveness and the high and likely underestimated budgetary impact on the Public health.
Statement of the European Union and its Member States on World AIDS Day, 2011 see here>>>
Advocacy - is a series of activities targeted at decision makers and politicians with the aim to promote specific political issues. The process of advocacy is considered completed when the decision is taken and specific actions are carried out accordingly. In general advocacy is a process of continual response to the situation, attitudes, policies and legislation through influence upon decision makers and authorities, as well as structures and systems of different levels in order to improve the situation of people affected by a specific problem.
Partnership Agreement between the Ministry of Health of the Republic of Latvia, the Ministry of Social Affairs of the Republic of Estonia and the Ministry of Health of the Republic of Lithuania on Joint Procurements of Medicinal Products and Medical Devices and Lending of Medicinal Products and Medical Devices Procurable Centrally. Read the Agreement herehttp://www.likumi.lv/doc.php?id=248008
+371 26062077 
apvieniba@apvienibahiv.lv